SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-24-008868
Filing Date
2024-03-21
Accepted
2024-03-21 16:47:01
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dmtp20240315_s3.htm S-3 293420
2 EXHIBIT 5.1 ex_642087.htm EX-5.1 43808
3 EXHIBIT 5.2 ex_641543.htm EX-5.2 26588
4 EXHIBIT 23.1 ex_641544.htm EX-23.1 2998
5 EXHIBIT FILING FEES ex_640485.htm EX-FILING FEES 53532
6 a01.jpg GRAPHIC 17535
7 dmtp20240315_s3img001.jpg GRAPHIC 7066
8 dmtp20240315_s3img003.jpg GRAPHIC 7066
9 fax.jpg GRAPHIC 821
10 footer.jpg GRAPHIC 10118
11 fr.jpg GRAPHIC 3640
12 graph0001.jpg GRAPHIC 29443
13 phone.jpg GRAPHIC 778
  Complete submission text file 0001437749-24-008868.txt   527738
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278146 | Film No.: 24772009
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)